AbCellera Biologics Deal History & Licensing Activity
AbCellera Biologics is a biotech headquartered in Canada. Over the past three years, AbCellera Biologics has been involved in 2 licensing and acquisition transactions, with a primary focus on Bispecific Antibodies (4 deals). The company currently has 3 active clinical trials, primarily in Immunology.
Deals (12mo)
2
Active Trials
3
Top Modality
Bispecific Antibodies
Focus Area
Immunology
AbCellera Biologics Recent Deal Activity
Licensing, acquisition, and partnership transactions involving AbCellera Biologics in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| T-cell engager / multispecific antibody platform | Vertex Pharmaceuticals Incorporated | Bispecific Antibodies | Discovery | collaboration | Jul 29, 2026 |
| T-cell engaging multispecific antibodies program | Jazz Pharmaceuticals | Bispecific Antibodies | Discovery | option | Jun 17, 2026 |
AbCellera Biologics Pipeline Focus
Therapeutic areas and modalities where AbCellera Biologics is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
AbCellera Biologics Clinical Pipeline
AbCellera Biologics has 3 active clinical trials across 1 development phase.
3
Phase 1
See How Your Asset Matches AbCellera Biologics's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Immunology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Immunology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for immunology
Bispecific Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for bispecific antibodies deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About AbCellera Biologics Licensing & Deal Activity
AbCellera Biologics is a biotech company based in Canada that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, AbCellera Biologics ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for AbCellera Biologics include Immunology (2 deals and trials), Other (2 deals and trials), and Womens Health (2 deals and trials). In terms of modality, AbCellera Biologics has shown particular interest in bispecific antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for AbCellera Biologics and 700+ other biopharma companies. Use our Solidus to benchmark your asset against AbCellera Biologics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.